Choose an evidence-first peptide research path for repair, metabolism, cognition, aging, safety, quality, comparisons, protocol math, or source review.

Peptide Research by Goal: Evidence-First Use Cases

Start with the question you need to answer—not a product name, stack, or promised outcome. PepGuide's use-case paths connect broad research intent to the most relevant comparison, profile, primary-source workflow, quality guide, or calculator while keeping evidence, safety, and commercial availability separate.

A use case is a way to organize research. It is not a treatment recommendation, evidence that every compound in a category works, or a substitute for professional care.

Choose your starting point

I know the peptide name

Find aliases, mechanisms, evidence stage, safety context, pharmacokinetics, protocols, and references in one profile.

I know the research area

Browse metabolic, repair, cognitive, immune, longevity, and other categories without treating a category as a clinical indication.

I need to compare options

Start with evidence-focused comparisons of mechanism, formulation, route, research maturity, and important limitations.

I need to verify a claim

Resolve identity, then check publications, registered human studies, regulatory records, and product-specific evidence separately.

I need to inspect quality records

Separate identity, purity, amount, potency, sterility, endotoxin, stability, and batch traceability instead of relying on one COA number.

I need source availability

Review separately disclosed availability and batch-record links after researching the compound and the limits of its evidence.

Research paths by goal

These paths organize the literature by question. They do not imply that a compound is approved, effective, or appropriate for a person.

Tissue repair, wound, tendon, or recovery claims

Map the repair evidence

Compare BPC-157, thymosin beta-4/TB-500, GHK-Cu, KPV, and related claims by exact molecule, model, route, and human-evidence boundary.

Audit BPC-157 claims

Review human evidence, animal research, current trial records, FDA context, anti-doping status, and dosing limitations.

Question to carry forward: Is the claim based on cells, an injury model in animals, observational data, or a controlled human outcome—and is the offered material the same molecule and formulation?

Metabolism, weight, appetite, and glucose research

Compare incretin approaches

Compare semaglutide, tirzepatide, retatrutide, cagrilintide, and related programs by target, trial phase, outcomes, and regulatory status.

Research semaglutide

Inspect the compound-specific mechanism, approved-product context, evidence, safety, pharmacokinetics, and source references.

Question to carry forward: Does the evidence concern an approved product and indication, a different dose or population, an investigational analog, or a preclinical mechanism?

Growth hormone and IGF-1 pathway questions

Compare secretagogue mechanisms

Compare receptor action, hormone selectivity, human evidence, appetite effects, FDA status, and safety limits.

Understand GH–IGF-1 biology

Review the axis, binding proteins, laboratory interpretation, approved uses, feedback loops, and evidence limits before interpreting a protocol.

Question to carry forward: Is the study measuring a short hormone pulse, integrated exposure, IGF-1, body composition, symptoms, or a clinically meaningful outcome?

Cognition, neuroprotection, mood, or sleep claims

Map brain-related evidence

Compare Semax, Selank, Cerebrolysin, Dihexa, DSIP, and related compounds without treating animal neurobiology as proof of human benefit.

Research Semax

Follow the exact formulation, jurisdiction, study population, route, endpoints, and safety evidence rather than relying on the nootropic label.

Question to carry forward: Was the exact peptide administered to people, or does the claim come from a biomarker, cell system, animal model, related analog, or regional product label?

Immune, inflammatory, antimicrobial, or gut questions

Audit KPV gut claims

Separate melanocortin biology, cell and animal findings, formulation questions, and the absence or presence of direct human intervention evidence.

Research thymosin alpha-1

Review immune mechanisms, jurisdiction-specific products, clinical study contexts, interactions, safety, and source references.

Question to carry forward: Does “immune support” refer to a measured pathway, infection outcome, inflammatory marker, licensed indication in one jurisdiction, or marketing language?

Longevity, mitochondrial, and hallmarks-of-aging research

Use the hallmarks evidence map

Compare FOXO4-DRI, Epitalon, Humanin, GHK-Cu, BPC-157, and other interventions by hallmark, evidence level, and safety status.

Separate Humanin from HNG

Distinguish native Humanin, the HNG analog, animal intervention studies, observational human data, and biomarker-only trial records.

Question to carry forward: Is the endpoint a molecular hallmark, a biomarker association, function in an animal, healthspan, disease outcome, or survival in people?

Skin, hair, and cosmetic claims

Compare cosmetic peptides

Review signal peptides, carrier peptides, topical formulation, skin endpoints, study design, and the gap between an ingredient and a finished product.

Research GHK-Cu

Separate native GHK, copper complexes, route-specific evidence, wound and skin studies, safety boundaries, and product-quality questions.

Question to carry forward: Was the tested material the isolated peptide, a copper complex, a cosmetic ingredient blend, or the same finished formulation being discussed?

Research paths by task

Assess evidence quality

Read a study critically

Identify the design, population, comparator, sample size, endpoint, effect size, uncertainty, conflicts, and translation limits.

Review PepGuide methodology

See how sources are selected, how evidence stages are separated, and why editorial claims do not inherit commercial status.

Check regulatory or safety status

Check regulatory status

Use regulator-owned records and distinguish approval, investigation, compounding, scheduling, anti-doping rules, and jurisdiction.

Verify in primary databases

Resolve identity, inspect publications and human-study records, and match approval claims to the exact product, route, and indication.

Evaluate a product or certificate

Interpret HPLC, MS, and COAs

Learn what each method measures and why identity, purity, amount, potency, sterility, and endotoxin are separate claims.

Check stability and handling evidence

Evaluate product-specific storage, diluent, container, in-use period, and stability data without relying on universal shelf-life rules.

Check protocol math

Use the concentration calculator

Model concentration, volume, and syringe-unit conversions from values you provide; the arithmetic does not establish an appropriate dose.

Verify route and formulation context

Check whether the evidence concerns the same route, formulation, exposure measure, and product before doing any conversion.

From a search question to a defensible answer

Write the claim precisely. Include the peptide, analog, population, outcome, route, and time frame.
Resolve identity. Check aliases, sequence, formulation, conjugates, salts, and whether the study material matches the claimed product.
Classify the evidence. Separate cell, animal, observational human, interventional human, review, and approved-label evidence.
Inspect the primary source. Read methods, comparator, enrollment, endpoint, effect size, uncertainty, adverse events, and conflicts.
Check current status. Verify trial, approval, compounding, anti-doping, and jurisdictional claims in the appropriate official source.
Evaluate quality independently. A COA cannot establish efficacy, and a paper cannot validate an offered batch.
Use tools only for the question they answer. A calculator checks arithmetic; it does not supply a protocol or safety decision.
Review availability last. Read the sourcing and commercial policy, then use the source directory only if availability or batch documentation is independently relevant.

What each layer can answer

Layer	Useful question	Cannot establish by itself
Peptide profile	What is the compound, mechanism, evidence stage, and safety context?	That it is appropriate for a particular person
Research guide or comparison	How do related claims and studies differ?	Product equivalence or individualized benefit
Primary paper or trial record	What exact study was performed and reported?	Approval, replication, or applicability beyond its design
Regulatory database	Is a specific product approved for a specific use in a jurisdiction?	That a different product, route, or use shares that status
Calculator	Is the supplied concentration or unit conversion arithmetically consistent?	A safe dose, valid protocol, or suitable product
Batch documentation	What did a stated method report for a stated lot?	Human efficacy, approval, or every quality attribute
Source directory	What availability and documentation links are currently reported?	Endorsement, medical suitability, or evidence strength

Frequently asked questions

Which peptide is best for a goal?

There is no evidence-based universal “best peptide” for a broad goal. The answer changes with the exact compound, indication, population, comparator, endpoint, formulation, route, evidence maturity, safety constraints, and jurisdiction. Use the relevant evidence map to narrow the question rather than starting with a ranking.